TLT8 is a ByeTAC protein degrader targeting BTK. TLT8 non-covalently binds to Rpn-13 and BTK, thereby inducing BTK degradation. TLT8 can be used in chronic lymphocytic leukemia research. (Rpn-13 ligand: HY-159808, BTK ligand: HY-Z3101, linker: HY-172823)[1].
Molecular Weight:
1340.77
Formula:
C63H76BrClN12O12S
Target:
Btk,ByeTAC
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
